Maravai LifeSciences Holdings, Inc. MRVI Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s total liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported total liabilities of $344.13M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s total liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s total liabilities decreased by 19.9% year-over-year, from $429.48M to $344.13M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s total liabilities has grown at a -18.6% compound annual growth rate (CAGR), from $1.12B to $397.87M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.